Big Move For Ignyta, Inc.
Fri, Jan 14, 2022 at 05:30 PM
Ignyta, Inc. (RXDX:NASDAQ) jumped higher at $35.29, representing a gain of 17.1%. On Thu, Jan 13, 2022, RXDX:NASDAQ touched a New 2-Week Low of $30.13. The stock got featured on our News Catalysts scanner on Wed, Jan 12, 2022 at 11:26 AM in the 'INVESTOR UPDATE' category. From Thu, Dec 30, 2021, the stock recorded 20.00% Up Days and 45.45% Green Days
About Ignyta, Inc. (RXDX:NASDAQ)
Ignyta Inc is a precision oncology biotechnology company. Its research is targeting tumor reduction and cancer treatment through both integrated therapeutic and companion diagnostics. It aims to develop and commercialize molecularly targeted therapies.
Top 10 Gainers:
- GFAI (GFAI:NASDAQ), 54.29%
- MYNZ (MYNZ:NASDAQ), 26.95%
- ATIP (ATIP:NYSE), 23.36%
- THRX (THRX:NASDAQ), 23.21%
- ShiftPixy, Inc. (PIXY:NASDAQ), 22.86%
- Integrated Media Technology Limited (IMTE:NASDAQ), 19.81%
- Ignyta, Inc. (RXDX:NASDAQ), 17.13%
- Melco Resorts & Entertainment Limited (MLCO:NASDAQ), 16.6%
- CRDL (CRDL:NASDAQ), 16.28%
- UK (UK:NASDAQ), 15.38%